Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
4.700
-0.050 (-1.05%)
Jul 7, 2025, 4:00 PM - Market closed
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $752.73 million as of July 8, 2025. Its market cap has increased by 138.37% in one year.
Market Cap
752.73M
Enterprise Value
963.04M
1-Year Change
138.37%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $752.73M, an increase of 154.49%. That is a compound annual growth rate of 28.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 752.73M | 48.94% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |